MYCOBUTIN Capsules Ref.[8365] Active ingredients: Rifabutin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2015  Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Product name and form

Mycobutin 150 mg capsules.

Pharmaceutical Form

Hard capsule.

Opaque, red-brown, Size NĀ°. 0 hard gelatin capsules.

Qualitative and quantitative composition

Each capsule contains 150.0 mg of rifabutin.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Rifabutin

Rifabutin is an antibiotic used to treat tuberculosis and prevent and treat Mycobacterium avium complex.
List of Excipients

Microcrystalline cellulose
Sodium lauryl sulfate
Magnesium stearate
Silica gel

Pack sizes and marketing

Transparent PVC/Al blisters in cardboard cartons containing 30 capsules.

Marketing authorization holder

Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

Marketing authorization dates and numbers

PL 00057/1017

15th January 2003

Drugs

Drug Countries
MYCOBUTIN Austria, Australia, Canada, Estonia, Hong Kong, Ireland, Israel, Japan, Netherlands, New Zealand, Turkey, United Kingdom, United States, South Africa
 
Next: Usage >

Ā© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈